A Comparison of the Effects of Tiotropium (18 Mcg) Inhalation Capsule q.d. and Salmeterol (50 Mcg) Inhalation Aerosol b.i.d. on Arterial Blood Gases in a Double-blind, Double-dummy, 4-week Crossover Study in Patients With Chronic Obstructive Pulmonary Disease (COPD).

  • NCT00274534
  • PHASE3
  • INTERVENTIONAL

Last updated: 2013-11-05

Purpose of  Trial

To evaluate changes in PaO2 following inhalation of Tiotropium by HandiHaler compared to Salmeterol MDI in patients with moderate to severe COPD.


This study is for people with

Pulmonary Disease, Chronic Obstructive


Interventions being studied

Tiotropium

Salmeterol

Register to Save
ELIGIBILITY

Gender: ALL

Age: 50+

Healthy Volunteers: No

2 Locations
Hines

Hines Veterans Administration Hospital


Illinois, United States
Richmond

Hunter Holmes McGuire Medical Center


Virginia, United States
Primary Contact(s)

Boehringer Ingelheim

Data obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Learn more at ClinicalTrials.gov

Back to Results New Search